Better eating habits, can save your life and the planet as well, new study says.
UNITED STATES (Kaiser Health News) – In the United States, at least 4.6 million people have been infected and nearly 155,000 have died, in Mexico there are almost 450 thousand infections and almost 50 thousand deaths. However, there is an epidemic in both countries that precedes COVID-19. It is obesity.
In the US The prevalence of obesity was 42.4% in 2017-2018 according to reports from the CDC. Non-Hispanic blacks had the highest age-adjusted prevalence of obesity, 49.6%, followed by Hispanics with 44.8%, non-Hispanic whites 42.2% and non-Hispanic Asians with 17.4%.
The prevalence of obesity was 40.0% among young adults aged 20 to 39 years, 44.8% among middle-aged adults aged 40 to 59 years, and 42.8% among adults aged 60 and older.
In Mexico, 70% of Mexicans are overweight and almost a third suffer from obesity. In addition, this disease is mainly associated with diabetes and cardiovascular disease, but also with bone and muscle disorders and some types of cancer.
Scientists know that vaccines engineered to protect the public from influenza, hepatitis B, tetanus and rabies can be less effective in obese adults than in the general population, leaving them more vulnerable to infection and illness. There is little reason to believe, obesity researchers say, that Covid-19 vaccines will be any different.
“Will there be a Covid vaccine next year tailored to the obese? -No.” said Raz Shaikh, an associate professor of nutrition at the University of North Carolina-Chapel Hill. “Will it still work in the obese? -Our prediction is no.”
More than 107 million Americans and 84 million Mexicans are obese, and their ability to return safely to work, care for their families and resume daily life could be curtailed if the coronavirus vaccine delivers weak immunity for them.
In March, still early in the global pandemic, a little-noticed study from China found that heavier Chinese patients afflicted with Covid-19 were more likely to die than leaner ones, suggesting a perilous future awaited the US, whose population is among the heaviest in the world.
As intensive care units in New York, New Jersey and elsewhere filled with patients, the federal Centers for Disease Control and Prevention warned that obese people with a body mass index of 40 or more — known as morbid obesity or about 100 pounds overweight — were among the groups at highest risk of becoming severely ill with Covid-19. About 9% of American adults are in that category.
As weeks passed and a clearer picture of who was being hospitalized came into focus, federal health officials expanded their warning to include people with a body mass index of 30 or more. That vastly expanded the ranks of those considered vulnerable to the most severe cases of infection, to 42.4% of American adults.
Obesity intereferes with immune response
Obesity has long been known to be a significant risk factor for death from cardiovascular disease and cancer. But scientists in the emerging field of immunometabolism are finding obesity also interferes with the body’s immune response, putting obese people at greater risk of infection from pathogens such as influenza and the novel coronavirus.
In the case of influenza, obesity has emerged as a factor making it more difficult to vaccinate adults against infection. The question is whether that will hold true for Covid-19.
A healthy immune system turns inflammation on and off as needed, calling on white blood cells and sending out proteins to fight infection. Vaccines harness that inflammatory response. But blood tests show that obese people and people with related metabolic risk factors such as high blood pressure and elevated blood sugar levels experience a state of chronic mild inflammation; the inflammation turns on and stays on.
Adipose tissue — or fat — in the belly, the liver and other organs is not inert; it contains specialized cells that send out molecules, like the hormone leptin, that scientists suspect induces this chronic state of inflammation. While the exact biological mechanisms are still being investigated, chronic inflammation seems to interfere with the immune response to vaccines, possibly subjecting obese people to preventable illnesses even after vaccination.
An effective vaccine fuels a controlled burn inside the body, searing into cellular memory a mock invasion that never truly happened.
Evidence that obese people have a blunted response to common vaccines was first observed in 1985 when obese hospital employees who received the hepatitis B vaccine showed a significant decline in protection 11 months later that was not observed in non-obese employees. The finding was replicated in a follow-up study that used longer needles to ensure the vaccine was injected into muscle and not fat.
Researchers found similar problems with the hepatitis A vaccine, and other studies have found significant declines in the antibody protection induced by tetanus and rabies vaccines in obese people.
“Obesity is a serious global problem, and the suboptimal vaccine-induced immune responses observed in the obese population cannot be ignored,” pleaded researchers from the Mayo Clinic’s Vaccine Research Group in a 2015 study published in the journal Vaccine.
Vaccines also are known to be less effective in older adults, which is why those 65 and older receive a supercharged annual influenza vaccine that contains far more flu virus antigens to help juice up their immune response.
By contrast, the diminished protection of the obese population — both adults and children — has been largely ignored.
“I’m not entirely sure why vaccine efficacy in this population hasn’t been more well reported,” said Catherine Andersen, an assistant professor of biology at Fairfield University who studies obesity and metabolic diseases. “It’s a missed opportunity for greater public health intervention.”
In 2017, scientists at the University of North Carolina – Chapel Hill provided a critical clue about the limitations of the influenza vaccine. In a paper published in the International Journal of Obesity, researchers showed for the first time that vaccinated obese adults were twice as likely to develop influenza or flu-like illness compared with adults of a healthy weight.
Curiously, the study found that adults with obesity did produce a protective level of antibodies to the influenza vaccine, but these adults still responded poorly.
One hypothesis, is that obesity may trigger a metabolic dysregulation of T cells, white blood cells critical to the immune response. “It’s not insurmountable,” said Petit, who is researching Covid-19 in obese patients. “We can design better vaccines that might overcome this discrepancy.”
Historically, people with high BMIs often have been excluded from drug trials because they frequently have related chronic conditions that might mask the results. The clinical trials underway to test the safety and efficacy of a coronavirus vaccine do not have a BMI exclusion and will include people with obesity, said Dr. Larry Corey, of the Fred Hutchinson Cancer Research Center, who is overseeing the phase III trials sponsored by the National Institutes of Health.
Although trial coordinators are not specifically focused on obesity as a potential complication, Corey said, participants’ BMI will be documented and results evaluated.
The Yucatan Times
more recommended stories
San Antonio, TX could be hosting Canelo vs Smith
If you’re a boxing fan, you’re.
Randy Arozarena: from the World Series to Mérida’s CERESO in less than a month
Interviewed at her home in the.
Donald Trump pardoned his former security advisor Michael Flynn.
“I know you will now have.
Mayan communities of Campeche deliver 268 thousand signatures against the Mayan Train.
The protesters stated that the Mayan.
Cenote divers in Tulum must be regulated by Civil Protection
Tulum, Q.R. — The Directorate of.
86 percent progress reported in the Mérida – Chetumal highway repaving works
Mérida, Yucatán (November 25, 2020).- The.
Lucas de Galvez and San Benito markets will close until 9 PM
MÉRIDA.- In response to the requests.
CDC warns Americans against traveling to Mexico due to COVID-19
People who become infected with the.
Are hurricanes spurring more Central American migration?
SAN PEDRO SULA, Honduras (AP) —.
If approved by Cofepris, Pfizer vaccine will arrive in December: Marcelo Ebrard
On Tuesday, November 24th, Marcelo Ebrard,.